1034682--9/29/2008--HERITAGE_WORLDWIDE_INC

related topics
{product, candidate, development}
{regulation, government, change}
{customer, product, revenue}
{product, market, service}
{stock, price, share}
{cost, regulation, environmental}
{product, liability, claim}
{financial, litigation, operation}
{operation, international, foreign}
{capital, credit, financial}
{cost, operation, labor}
{tax, income, asset}
{personnel, key, retain}
{property, intellectual, protect}
{stock, price, operating}
{condition, economic, financial}
Certain risk factors which may impact our business, results of operations and financial condition IF WE ARE UNABLE TO AVOID SIGNIFICANT PRODUCT LIABILITY CLAIMS OR PRODUCT RECALLS, WE MAY BE FORCED TO PAY SUBSTANTIAL DAMAGE AWARDS AND OTHER EXPENSES THAT COULD EXCEED OUR ACCRUALS AND INSURANCE COVERAGE. IF WE ARE UNABLE TO INCREASE OUR REVENUES OR FIND ADEQUATE SOURCE OF FINANCING FOR OUR OPERATIONS, WE MAY NOT BE ABLE TO CONTINUE AS A GOING CONCERN. THE SUCCESS OF OUR BUSINESS IS SUBSTANTIALLY DEPENDENT ON THE SALES OF BREAST IMPLANTS. IF WE ARE UNABLE TO CONTINUE TO DEVELOP AND MARKET NEW PRODUCTS AND TECHNOLOGIES, WE MAY EXPERIENCE A DECREASE IN DEMAND FOR OUR PRODUCTS OR OUR PRODUCTS COULD BECOME OBSOLETE. IF CLINICAL TRIALS FOR OUR PRODUCTS ARE UNSUCCESSFUL OR DELAYED, WE WILL BE UNABLE TO MEET OUR ANTICIPATED DEVELOPMENT AND COMMERCIALIZATION TIMELINES, AND OUR BUSINESS PROSPECTS WILL SUFFER. WE ARE SUBJECT TO SUBSTANTIAL GOVERNMENT REGULATION, WHICH COULD MATERIALLY ADVERSELY AFFECT OUR BUSINESS. HEALTHCARE REFORM LEGISLATION COULD MATERIALLY ADVERSELY AFFECT OUR BUSINESS. IF WE ARE UNABLE TO ADEQUATELY PROTECT OUR INTELLECTUAL PROPERTY RIGHTS RELATED TO OUR PRODUCTS OR TECHNOLOGIES, OR WE INFRINGE UPON THE INTELLECTUAL PROPERTY RIGHTS OF OTHERS, WE MAY NOT BE ABLE TO SUCCESSFULLY DEVELOP AND COMMERCIALIZE OUR PRODUCTS AND MAINTAIN PROFITABILITY. IF OUR COLLABORATIVE PARTNERS DO NOT PERFORM, WE WILL BE UNABLE TO DEVELOP AND MARKET PRODUCTS AS ANTICIPATED. IF WE FAIL TO PREVAIL IN A CLAIM THAT WE OWE OUR FORMER U.S. DISTRIBUTOR MORE THAN $1.5 MILLION, IT MAY ADVERSELY IMPAIR OUR FINANCIAL POSITION, NET INCOME AND CASH FLOWS. WE DEPEND ON A LIMITED NUMBER OF SUPPLIERS FOR CERTAIN PRODUCTS AND RAW MATERIALS AND THE LOSS OF ANY SUPPLIER COULD ADVERSELY AFFECT OUR ABILITY TO MANUFACTURE MANY OF OUR PRODUCTS. OUR INTERNATIONAL BUSINESS EXPOSES US TO A NUMBER OF RISKS. WE RELY ON INDIRECT DISTRIBUTION CHANNELS AND MAJOR DISTRIBUTORS THAT WE DO NOT CONTROL. IF OUR USE OF HAZARDOUS MATERIALS RESULTS IN CONTAMINATION OR INJURY, WE COULD SUFFER SIGNIFICANT FINANCIAL LOSS. OUR STOCK PRICE HAS BEEN VOLATILE AND OUR TRADING VOLUME HAS HISTORICALLY BEEN LOWER THAN THAT OF MOST PUBLICLY-TRADED COMPANIES. OUR REPORTED EARNINGS PER SHARE MAY BE MORE VOLATILE BECAUSE OF THE CONTINGENT CONVERSION PROVISION OF OUR DEBENTURES. IF WE DETERMINE THAT ANY OF OUR GOODWILL OR INTANGIBLE ASSETS IS IMPAIRED, WE WOULD BE REQUIRED TO RECORD A CHARGE TO EARNINGS, WHICH COULD HAVE A MATERIAL ADVERSE EFFECT ON OUR RESULTS OF OPERATIONS. IF WE FAIL TO MANAGE OUR OPERATIONS OR FAIL TO CONTINUE TO EFFECTIVELY CONTROL EXPENSES, OUR REVENUES, RESUTS OF OPERATIONS AND CASH FLOW FROM OPERATIONS COULD DECREASE. WE COULD CHANGE OUR MARKETING PROGRAMS, WHICH COULD NEGATIVELY IMPACT THE TIMING OF OUR RECOGNITION OF REVENUES. IF WE LOSE KEY PERSONNEL, CANNOT INTEGRATE NEWLY HIRED PERSONNEL, OR CANNOT HIRE ENOUGH QUALIFIED EMPLOYEES, OUR ABILITY TO MANAGE OUR BUSINESS COULD BE ADVERSELY AFFECTED.

Full 10-K form ▸

related documents
880432--9/26/2008--MISONIX_INC
780127--1/12/2006--SYNOVIS_LIFE_TECHNOLOGIES__INC
856982--3/4/2009--MERIT_MEDICAL_SYSTEMS_INC
838879--4/15/2009--AMDL_INC
1099800--2/26/2010--Edwards_Lifesciences_Corp
1099800--3/2/2009--Edwards_Lifesciences_Corp
1026650--3/3/2010--ERESEARCHTECHNOLOGY_INC_/DE/
1123361--3/6/2007--VIASYS_HEALTHCARE_INC
1123361--3/14/2006--VIASYS_HEALTHCARE_INC
886530--3/16/2009--DATATRAK_INTERNATIONAL_INC
875657--3/13/2009--ULTRALIFE_CORP
880432--9/28/2009--MISONIX_INC
881890--6/14/2010--ABAXIS_INC
5768--6/13/2007--AMERICAN_SCIENCE_&_ENGINEERING_INC
5768--6/13/2008--AMERICAN_SCIENCE_&_ENGINEERING_INC
1022079--3/1/2007--QUEST_DIAGNOSTICS_INC
31791--3/1/2010--PERKINELMER_INC
780127--1/7/2009--SYNOVIS_LIFE_TECHNOLOGIES__INC
5768--6/15/2009--AMERICAN_SCIENCE_&_ENGINEERING_INC
731012--2/20/2009--HEALTHCARE_SERVICES_GROUP_INC
38074--5/30/2007--FOREST_LABORATORIES_INC
38074--5/30/2008--FOREST_LABORATORIES_INC
913165--3/16/2007--EXACTECH_INC
752294--3/26/2010--ELECTRONIC_SYSTEMS_TECHNOLOGY_INC
806517--3/27/2009--PSYCHEMEDICS_CORP
880432--9/28/2010--MISONIX_INC
932696--5/12/2009--INSIGHT_ENTERPRISES_INC
1087216--12/29/2008--ALLIANCE_HEALTHCARD_INC
1041024--3/24/2008--ROCKWELL_MEDICAL_TECHNOLOGIES_INC
894253--2/25/2009--PEROT_SYSTEMS_CORP